Literature DB >> 9106310

ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.

J M Puck1, M C Sneller.   

Abstract

Apoptosis of activated lymphocytes is critical to immune homeostasis. The cell surface receptor Fas is an important mediator of lymphocyte apoptosis; defective Fas expression causes accumulation of lymphocytes and autoimmune disease in mice. Apoptosis defects due to mutations of Fas have also been found in a rare human autoimmune lymphoproliferative syndrome (ALPS). Nine unrelated children with ALPS had lymphadenopathy, autoimmunity and expansion of a normally infrequent population of CD4-CD8-T cells. All nine exhibited impaired lymphocyte apoptosis in vitro, and eight had heterozygous Fas gene mutations. Thus genetic defects in apoptosis pathways are implicated in the pathogenesis of at least one human autoimmune disorder.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9106310     DOI: 10.1006/smim.1996.0056

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  11 in total

Review 1.  A portrait of the Bcl-2 protein family: life, death, and the whole picture.

Authors:  M Pellegrini; A Strasser
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

2.  Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients.

Authors:  T Otsuki; A Tomokuni; H Sakaguchi; T Aikoh; T Matsuki; Y Isozaki; F Hyodoh; H Ueki; M Kusaka; S Kita; A Ueki
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

Review 3.  Multiple mechanisms of immune suppression by B lymphocytes.

Authors:  Matthew W Klinker; Steven K Lundy
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 4.  The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function.

Authors:  F K Chan
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

5.  Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice.

Authors:  Y Zhang; S F Schlossman; R A Edwards; Ching-Nan Ou; J Gu; Mei X Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

6.  Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas.

Authors:  Irina Bonzheim; Eva Geissinger; Wen-Yu Chuang; Sabine Roth; Philipp Ströbel; Alexander Marx; Peter Reimer; Martin Wilhelm; Bernhard Puppe; Andreas Rosenwald; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  J Hematop       Date:  2008-04-24       Impact factor: 0.196

7.  Dietary n-3 PUFAs augment caspase 8 activation in Staphylococcal aureus enterotoxin B stimulated T-cells.

Authors:  R Gill; K L Jen; M J J McCabe; A Rosenspire
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-07       Impact factor: 4.219

8.  Susceptibility to acute rheumatic fever based on differential expression of genes involved in cytotoxicity, chemotaxis, and apoptosis.

Authors:  Penelope A Bryant; Gordon K Smyth; Travis Gooding; Alicia Oshlack; Zinta Harrington; Bart Currie; Jonathan R Carapetis; Roy Robins-Browne; Nigel Curtis
Journal:  Infect Immun       Date:  2013-12-02       Impact factor: 3.441

9.  Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity.

Authors:  Kevin Goudy; Didem Aydin; Federica Barzaghi; Eleonora Gambineri; Marina Vignoli; Sara Ciullini Mannurita; Claudio Doglioni; Maurilio Ponzoni; Maria Pia Cicalese; Andrea Assanelli; Alberto Tommasini; Immacolata Brigida; Rosa Maria Dellepiane; Silvana Martino; Sven Olek; Alessandro Aiuti; Fabio Ciceri; Maria Grazia Roncarolo; Rosa Bacchetta
Journal:  Clin Immunol       Date:  2013-01-24       Impact factor: 3.969

10.  RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells.

Authors:  Y W He; M L Deftos; E W Ojala; M J Bevan
Journal:  Immunity       Date:  1998-12       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.